WELL Ventures is pleased to report that its portfolio companies continue to raise funds at attractive valuations with high quality capital allocators globally.

WELL Ventures很高兴报告其投资组合公司继续以全球高质量资本分配商的有吸引力的估值筹集资金。

Sun Life has invested $9.5 million in Pillway, a move that reinforces the value of Pillway's digital pharmacy platform within Sun Life's benefits management program.

Sun Life在Pillway投资了950万美元，这一举措加强了Pillway数字药房平台在Sun Life福利管理计划中的价值。

WELL Ventures has completed a new investment in ORX AI, a company that is leveraging advanced AI to optimize operating room efficiencies and streamline healthcare revenue management.

WELL Ventures已完成对ORX AI的新投资，该公司正在利用先进的AI来优化手术室效率并简化医疗保健收入管理。

WELL Ventures, investee doctorly GmbH, the only VC-backed startup in Germany authorized to sell practice management software, has attracted a new round of funding of €6.7M in Series A Extension. The Round was led by Dusseldorf based Simon Capital and included participation from Geschwister Oetker Beteiligungen KG, UNIQA Ventures and WELL's investee HEALWELL AI (TSX: AIDX)..

WELL Ventures，investee doctorly GmbH是德国唯一获得VC支持的授权销售业务管理软件的初创企业，在a系列延期中吸引了670万欧元的新一轮资金。该轮由位于杜塞尔多夫的西蒙首都领导，包括Geschwister-Oetker-Beteiligungen KG，UNIQA Ventures和WELL的investee HEALWELL AI（TSX:AIDX）的参与。。

VANCOUVER, BC and TORONTO, Nov. 30, 2023 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ('WELL' or the 'Company'), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients globally, is pleased to announce series of strategic investment developments that highlight its leadership in fostering innovation within the digital health technology sphere..

温哥华，不列颠哥伦比亚省和多伦多，2023年11月30日/PRNewswire/-WELL-Health-Technologies-Corp。（TSX:WELL）（OTCXX:WHTCF）（'WELL'或'Company'），一家专注于数字健康公司通过利用技术在全球范围内增强医疗服务提供者及其患者的权力，积极影响健康结果，很高兴宣布一系列战略投资发展，突出其在促进数字健康技术领域创新方面的领导地位。。

Hamed Shahbazi, Founder and CEO of WELL, stated, 'We are very pleased to announce our new investment in ORX AI and see our WELL Venture portfolio companies Pillway and doctorly continue to raise capital with exceptional partners in this difficult funding environment. We believe this is a testament to the quality of companies and operators that are at the heart of WELL's investment program and our rigorous approach in due diligence and post transaction execution..

WELL的创始人兼首席执行官Hamed Shahbazi表示，“我们非常高兴地宣布我们对ORX AI的新投资，并看到我们的风险投资组合公司Pillway和doctorly继续在这个困难的资金环境中与优秀合作伙伴筹集资金。我们相信这证明了作为WELL投资计划核心的公司和运营商的质量，以及我们在尽职调查和交易后执行方面的严谨方法。。

Amir Javidan, COO of WELL, added, 'We also continue to be committed to intentionally aligning ourselves with the success of our investees by establishing thoughtful commercial partnering agreements in addition to our allocation of capital. This approach is working and elevating the value of our investments while delivering real operational value to both WELL and our investee partners.'.

WELL的首席运营官Amir Javidan补充说：“除了我们的资本分配之外，我们还通过建立深思熟虑的商业合作协议，继续致力于有意地使自己与投资者的成功保持一致。这种方法正在努力提高我们投资的价值，同时为我们的投资合作伙伴提供真正的运营价值。

Sun Life Investment Elevates Pillway's Market Position

太阳生命投资提升了Pillway的市场地位

Earlier this week, Sun Life announced a strategic investment of $9.5 million in Simpill Health Inc. ('Pillway'). This investment follows Sun Life's launch of the Lumino Health™ Pharmacy app provided by Pillway in June 2023 to Sun Life Group Benefits Clients in Canada. The app currently offers the following features: access to live pharmacist support through chat or phone, prompt medication delivery within Canada, personalized medication pre-packaging, as well as convenient adherence tracking, refill & renewal management, and notifications via the app..

本周早些时候，Sun Life宣布在Simpill Health Inc.（'Pillway'）上进行950万美元的战略投资。这项投资是在Sun Life推出Lumino Health之后进行的™Pillway于2023年6月向Sun Life Group提供的药房应用程序为加拿大的客户带来好处。该应用程序目前提供以下功能：通过聊天或电话访问现场药剂师支持，在加拿大境内及时提供药物，个性化药物预包装，以及方便的依从性跟踪，补充和更新管理以及通过应用程序的通知。。

Pillway's digital pharmacy platform is now a key component of Sun Life's benefits management program. The platform's seamless integration into Sun Life's offerings demonstrate the tangible impact of Pillway's technology on improving the management and delivery of health benefits. Through this partnership, Pillway's digital platform is expected to enhance the user experience for Sun Life's clientele, reflecting WELL's continued investment in solutions that contribute to better patient care and efficient provider service..

Pillway的数字药房平台现在是Sun Life福利管理计划的关键组成部分。该平台与Sun Life产品的无缝集成展示了Pillway技术对改善健康益处管理和提供的实际影响。通过这种合作关系，Pillway的数字平台有望增强Sun Life客户的用户体验，反映WELL继续投资于有助于改善患者护理和高效供应商服务的解决方案。。

WELL Ventures Announces Investment in ORX AI to Amplify AI Program

WELL Ventures宣布投资ORX AI以扩大AI计划

WELL Ventures is pleased to announce its investment in ORX AI, a leader in AI healthcare technology, under its AI Investment Program. ORX AI's platform, Patient Compass transforms patient care by offering a user-friendly virtual agent that works alongside Electronic Medical Records (EMR) to allow patients to find care, get care, and advance care with greater ease..

WELL Ventures很高兴宣布在其AI投资计划下对AI医疗技术领导者ORX AI的投资。ORX AI的平台，患者指南针通过提供用户友好的虚拟代理来改变患者护理，该虚拟代理与电子病历（EMR）一起工作，使患者能够更轻松地找到护理，获得护理和提前护理。。

Patient Compass is designed to empower patients in their healthcare journey, allowing them to manage and share their health data between WELL's trusted AI products and providers. Patient Compass unlocks crucial healthcare data for many use cases like identifying rare diseases and updating care plans with the latest medical insights..

患者指南针旨在赋予患者在医疗保健过程中的权力，使他们能够在值得信赖的AI产品和提供商之间管理和共享他们的健康数据。患者指南针为许多用例解锁关键的医疗保健数据，如识别罕见疾病和更新护理计划以及最新的医学见解。。

WELL Ventures' investment in ORX AI is driven by WELL's commitment to empowering healthcare providers, and grew from the successful Digital Technology Supercluster project, Health Compass, announced on January 13, 2023. This collaboration highlighted each organization's shared commitment to advancing healthcare technology.

WELL Ventures对ORX AI的投资是由WELL致力于授权医疗保健提供者推动的，并源于2023年1月13日宣布的成功的数字技术超级集群项目Health Compass。这项合作突出了每个组织对推进医疗技术的共同承诺。

ORX AI stands out in the healthcare technology landscape for its ability to harness healthcare data for AI enablement to support providers in world-class care and is a strategic move to support WELL's ongoing deployment of WELL AI Decision Support through its exclusive partnership with HEALWELL AI..

ORX AI在医疗保健技术领域脱颖而出，因为它能够利用医疗保健数据实现AI支持世界一流医疗服务提供者，并且是通过与HEALWELL独家合作支持WELL持续部署良好AI决策支持的战略举措AI。。

doctorly Secures Additional VC Funding From Consortium Including HEALWELL AI

博士学位从包括HEALWELL AI在内的财团获得额外的VC资金

WELL Ventures investee doctorly GmbH ('doctorly'), has attracted a new round of funding of €6.7M in Series A Extension. The Round was led by Dusseldorf based Simon Capital and included participation from Geschwister Oetker Beteiligungen KG, UNIQA Ventures and WELL's affiliate HEALWELL AI. This is a follow-on from the initial investment announced in March 2023.

WELL Ventures investee doctorly GmbH（'doctorly'）在a系列延期中吸引了670万欧元的新一轮资金。该轮由位于杜塞尔多夫的西蒙首都领导，其中包括Geschwister Oetker-Beteiligungen KG，UNIQA Ventures和WELL的附属HEALWELL AI的参与。这是2023年3月宣布的初始投资的后续行动。

The investment underscores WELL's strategic focus on international growth and innovation in healthcare technology. As the only venture capital-backed startup in Germany authorized to sell practice management software, doctorly is uniquely positioned to transform the medical software landscape, already proving to reduce administrative time for healthcare providers..

这项投资强调了WELL对医疗技术国际增长和创新的战略关注。作为德国唯一授权销售业务管理软件的风险投资支持初创企业，博士学位处于改变医疗软件格局的独特地位，已经证明可以缩短医疗服务提供者的管理时间。。

This investment is poised to unlock the potential of patient EMR data through a strategic partnership between WELL, HEALWELL AI, and doctorly, aiming to tech-enable healthcare practitioners to improve patient care. The funds will boost doctorly's expansion in Germany, focusing on feature development that helps minimize administrative costs, thereby allowing healthcare professionals to dedicate more time to patient-focused services..

这项投资有望通过WELL，HEALWELL AI和博士学位之间的战略合作，释放患者EMR数据的潜力，旨在使技术使医疗保健从业者能够改善患者护理。这些资金将促进博士在德国的扩张，专注于功能开发，有助于最大限度地降低管理成本，从而使医疗保健专业人员可以将更多时间用于以患者为中心的服务。。

WELL continues to strategically allocate capital and form commercial partnering agreements with emerging tech firms, focusing on fostering a health innovation ecosystem in Canada and beyond. Through a disciplined investment process, WELL selectively backs opportunities that align strategically and financially.

WELL继续战略性地分配资本并与新兴技术公司形成商业合作协议，重点是在加拿大及其他地区建立健康创新生态系统。通过规范的投资流程，有选择地支持战略和财务上一致的机会。

This approach effectively nurtures healthcare innovations from their development phase through to their market launch, showcasing WELL's commitment to meaningful partnerships with tech firms. By providing guidance and resources, WELL not only accelerates these ventures but also reinforces its role in cultivating a sustainable health innovation ecosystem, further establishing itself as a leader in healthcare technology..

这种方法有效地促进了医疗保健创新从发展阶段到市场的推出，展示了WELL对与科技公司有意义合作关系的承诺。通过提供指导和资源，不仅可以加速这些企业的发展，而且可以加强其在培养可持续健康创新生态系统中的作用，进一步确立自己作为医疗技术领导者的地位。。

For additional information about WELL Ventures, its portfolio companies, and its AI investment program please visit https://well.ventures/.

有关WELL Ventures，其投资组合公司及其AI投资计划的更多信息，请访问https://well.ventures/.

WELL HEALTH TECHNOLOGIES CORP.

健康技术公司。

Per: 'Hamed Shahbazi'

收件人：“Hamed Shahbazi”

Hamed Shahbazi

Hamed Shahbazi

Chief Executive Officer, Chairman and Director

首席执行官，主席兼董事

About WELL Health Technologies Corp.

关于健康技术公司。

WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices.

WELL的使命是技术支持医疗保健提供者。我们通过开发可用的最佳技术，服务和支持来实现这一目标，确保医疗服务提供者有权对患者结果产生积极影响。WELL的综合医疗保健和数字平台包括广泛的前后办公室管理软件应用程序，帮助医生运行和保护他们的实践。

WELL's solutions enable more than 33,000 healthcare providers between the US and Canada, and power the largest owned and operated healthcare ecosystem in Canada with more than 150 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, mental health, revenue cycle management, and practitioner recruiting.

WELL的解决方案使美国和加拿大之间的33000多名医疗保健提供者成为可能，并为加拿大最大的拥有和运营的医疗保健生态系统提供动力，拥有150多家诊所，支持初级保健，专业护理和诊断服务。在美国，WELL的解决方案主要集中在专业市场，如胃肠市场，女性健康，初级保健，心理健康，收入周期管理和从业人员招聘。

WELL is publicly traded on the Toronto Stock Exchange under the symbol 'WELL' and on the OTC Exchange under the symbol 'WHTCF'. To learn more about the Company, please visit: www.well.company..

WELL在多伦多证券交易所以“WELL”符号公开交易，在场外交易所以“WHTCF”符号公开交易。要了解有关公司的更多信息，请访问：www.well.Company。。

SOURCE WELL Health Technologies Corp.

源井健康技术公司。